Literature DB >> 25053597

Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Yon Hee Kim1, Woo Hee Jung, Ja Seung Koo.   

Abstract

The purpose of this study is to investigate the difference in expression of metabolism-related proteins in invasive lobular carcinoma (ILC) compared to those of the invasive ductal carcinoma (IDC). Tissue microarray was manufactured for 114 cases of ILC and 692 cases of IDC. Immunohistochemical stains were performed as follows: glycolysis (Glut-1, hexokinase II, CAIX, MCT4), glutaminolysis (GLS1, GDH, ASCT2), mitochondria (ATP synthase, SDHA, SDHB), and serine/glycine metabolism (PHGDH, PSAT1, PSPH, SHMT1, GLDC) related proteins. Pleomorphic type (n = 12) of ILC revealed higher expression in hexokinase II, SDHB, and GLDC than classic type (n = 102) (p < 0.05). IDC showed a higher expression of glycolysis (Glut-1, CAIX, MCT4), glutaminolysis (GLS1, ASCT2), and serine/glycine metabolism (PSPH, SHMT1, GLDC) related protein than ILC in tumor cells, whereas ILC revealed higher expression in GDH, SDHA, PHGDH, and PSAT1 than IDC in tumor cells (p < 0.05). In addition, IDC demonstrated a higher expression of metabolism-related proteins than ILC in stromal tissue (p < 0.05). In ILC, tumoral GLDC positivity was correlated with higher nuclear grade (p = 0.026) and higher histologic grade (p = 0.026), and tumoral Glut-1 positivity correlated with higher histologic grade (p = 0.026). Additionally, tumoral PSPH positivity showed a significant correlation to ER negativity and PR negativity (p = 0.026). In conclusion, it reveals different expression patterns of metabolism-related proteins between IDC and ILC.

Entities:  

Mesh:

Year:  2014        PMID: 25053597     DOI: 10.1007/s13277-014-2345-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

Authors:  Eun-Jin Yeo; Yang-Sook Chun; Young-Suk Cho; Jinho Kim; June-Chul Lee; Myung-Suk Kim; Jong-Wan Park
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

3.  Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.

Authors:  D Frolik; R Caduff; Z Varga
Journal:  Histopathology       Date:  2001-11       Impact factor: 5.087

4.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

6.  Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.

Authors:  Daniela Vullo; Marco Franchi; Enzo Gallori; Jaromir Pastorek; Andrea Scozzafava; Silvia Pastorekova; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2003-03-24       Impact factor: 2.823

7.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

8.  Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.

Authors:  Junjeong Choi; Woo-Hee Jung; Ja Seung Koo
Journal:  Pathobiology       Date:  2012-07-24       Impact factor: 4.342

9.  Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Authors:  X Sastre-Garau; M Jouve; B Asselain; A Vincent-Salomon; P Beuzeboc; T Dorval; J C Durand; A Fourquet; P Pouillart
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.

Authors:  A C Klimowicz; P Bose; S K Petrillo; A M Magliocco; J C Dort; N T Brockton
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640

View more
  8 in total

1.  Functional Effects of Cigarette Smoke-Induced Changes in Airway Smooth Muscle Mitochondrial Morphology.

Authors:  Bharathi Aravamudan; Michael Thompson; Gary C Sieck; Robert Vassallo; Christina M Pabelick; Y S Prakash
Journal:  J Cell Physiol       Date:  2016-09-21       Impact factor: 6.384

2.  Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.

Authors:  Yoon Jin Cha; Hye Min Kim; Ja Seung Koo
Journal:  Int J Mol Sci       Date:  2017-01-23       Impact factor: 5.923

3.  Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.

Authors:  Tian Du; Li Zhu; Kevin M Levine; Nilgun Tasdemir; Adrian V Lee; Dario A A Vignali; Bennett Van Houten; George C Tseng; Steffi Oesterreich
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

4.  Identification and characterization of dysregulated P-element induced wimpy testis-interacting RNAs in head and neck squamous cell carcinoma.

Authors:  Maarouf A Saad; Jonjei Ku; Selena Z Kuo; Pin Xue Li; Hao Zheng; Michael Andrew Yu; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  Oncol Lett       Date:  2019-01-09       Impact factor: 2.967

5.  Expression of glutamine metabolism-related proteins in thyroid cancer.

Authors:  Hye Min Kim; Yu Kyung Lee; Ja Seung Koo
Journal:  Oncotarget       Date:  2016-08-16

6.  Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma.

Authors:  Cheng Qian; Yongsheng Xia; Yun Ren; Yan Yin; Anmei Deng
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

7.  Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer.

Authors:  Yun Xian; Shu Zhang; Xudong Wang; Jin Qin; Wei Wang; Han Wu
Journal:  Onco Targets Ther       Date:  2016-09-07       Impact factor: 4.147

Review 8.  The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.

Authors:  Ferdinando Chiaradonna; Francesca Ricciardiello; Roberta Palorini
Journal:  Cells       Date:  2018-06-02       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.